CypherPunk Technologies Faces Profit Crisis as Stock Falls Below $2
Explore why CypherPunk Technologies, a biotech Nasdaq stock, is struggling—negative P/E, steep price drop, and strategic challenges threaten its future.
2 minutes to read
CYPHERPUNK TECHNOLOGIES INC